Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard F. Ambinder

Showing results (81-90 of 218) with videos related to

Pageof 22
Sort By:
Leukemia & Lymphoma|January 19, 2019
R-CHOP without radiation in frontline management of primary mediastinal B-cell lymphomaMarcus Messmer, Hua-Ling Tsai, Ravi Varadhan, et al.
Scientific Reports|July 11, 2025
CD20-bearing extracellular vesicles are associated with prognostic biomarkers of patients with AIDS-NHLLaura E Martínez, Shelly Lensing, Di Chang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomasYvette L Kasamon, Richard J Jones, Christopher D Gocke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 26, 2017
Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma DiagnosisLynn I Levin, Elizabeth C Breen, Brenda M Birmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494)Joseph A Sparano, Sandra Lee, Michael G Chen, et al.
Epigenetics|October 30, 2007
Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomasJianming Ying, Hongyu Li, Paul Murray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2015
Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial)Marta Epeldegui, Jeannette Y Lee, Anna C Martínez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in bloodLan Lin, Jeannette Y Lee, Lawrence D Kaplan, et al.
Cancer|June 22, 2010
Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapyMary Cianfrocca, Sandra Lee, Jamie Von Roenn, et al.
Oncotarget|October 14, 2015
Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usageGenevieve M Crane, Helen Powell, Rumen Kostadinov, et al.
Pageof 22

Showing results (81-90 of 218) with videos related to

Sort By:
Pageof 22
Leukemia & Lymphoma|January 19, 2019
R-CHOP without radiation in frontline management of primary mediastinal B-cell lymphomaMarcus Messmer, Hua-Ling Tsai, Ravi Varadhan, et al.
Scientific Reports|July 11, 2025
CD20-bearing extracellular vesicles are associated with prognostic biomarkers of patients with AIDS-NHLLaura E Martínez, Shelly Lensing, Di Chang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomasYvette L Kasamon, Richard J Jones, Christopher D Gocke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 26, 2017
Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma DiagnosisLynn I Levin, Elizabeth C Breen, Brenda M Birmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494)Joseph A Sparano, Sandra Lee, Michael G Chen, et al.
Epigenetics|October 30, 2007
Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomasJianming Ying, Hongyu Li, Paul Murray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2015
Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial)Marta Epeldegui, Jeannette Y Lee, Anna C Martínez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in bloodLan Lin, Jeannette Y Lee, Lawrence D Kaplan, et al.
Cancer|June 22, 2010
Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapyMary Cianfrocca, Sandra Lee, Jamie Von Roenn, et al.
Oncotarget|October 14, 2015
Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usageGenevieve M Crane, Helen Powell, Rumen Kostadinov, et al.
Pageof 22